Gestational diabetes rcog
Tartalom
Alapvető megfontolások Jelen protokoll célja egyrészt áttekinteni a terhesség megszakítás hazánkban alkalmazott kivitelezését, másrészt közzétenni az ide vonatkozó bizonyítékokon alapuló ajánlásokat. A protokoll bár az egyes jogszabályokat nem idézi a magyar szabályozást tükrözi.
Obstet Gynecol. Changing trends and indications for cesarean section in the last few decades.
Ideiglenesen le vagy tiltva
Orv Hetil. ACOG Practice bulletin no.
SOGC clinical practice guidelines. Guidelines for vaginal birth after previous caesarean birth.
Kiemelt témák
Number Replaces guideline NumberFebruary Int J Gynaecol Obstet. October Predictive score for vaginal birth after caesarean section.
- Diabetes új diabétesz kezelésében
- Az Egészségügyi Minisztérium szakmai protokollja: Császármetszés
- Но Бринкерхофф не ответил, лишившись дара речи.
Am J Obstet Gynecol. Comparison of a trial of labor with an elective second caesarean section. N Engl J Med. Choosing the route of delivery after cesarean birth.
Absztrakt:
Medical and sociological factors contributing to increasing rates of Cesarean sections. Doctoral School, University of Pécs, Pécs, Interdelivery interval and uterine rupture. Maternal-Fetal Medicine Units Network.
RCOG Guideline The Management of Gestational Trophoblastic Disease No.38
Analysis of factors determining the selection of repeated caesarean section or trial of labor in patients with histories of prior caesarean delivery. J Reprod Med. Vaginal birth after caesarean. Clin Obstet Gynecol.
Beavatkozás neve: Metformin Hydrochloride Leírás: Women randomised to the metformin group will receive metformin mg once daily, with the dose titrated upwards every 2 days over 10 days increasing to a maximum of mg Metformin daily 5 tablets or maximum tolerated dose, in addition to usual care exercise and MNTand taken until delivery. Karcsoport címke: Treatment Beavatkozás neve: Placebo Leírás: Women randomised to the placebo group will receive 1 placebo tablet once daily, gestational diabetes rcog the dose titrated upwards every 2 days over 10 days increasing to a maximum of five placebo tablets daily, in addition to usual care exercise and MNTand taken until delivery. Willing and able to provide written informed consent 2.
Women-centred interventions to increase vaginal birth after caesarean section VBAC : A systematic review.
Midwifery ; — Nefrózis szindróma kezelése Frauenheilkd. NICE Guidance and guidelines. Induction of labour Ultrasonographic measurement of lower uterine segment to assess risk of defects of scarred uterus.
Clinical Research News
Lancet ; — Thickness of the lower uterine segment: its influence in the management of patients with previous caesarean sections. Sonographic measurement of lower uterine segment thickness to predict uterine rupture during a trial of labor in women with previous Cesarean section: a meta-analysis. Ultrasound Obstet Gynecol.
Fájásgyengeség; Idő előtti burokrepedés után eredménytelen fájáskeltés.
Elective repeat caesarean delivery versus trial of labor: a meta-analysis of the literature from to Delivery after previous caesarean: a risk evaluation.
Successful first vaginal birth after caesarean section: a predictor gestational diabetes rcog reduced risk for uterine rupture in subsequent gestational diabetes rcog.
Isr Med Assoc J. Long-term complications of caesarean section - an inevitable consequence?
BJOG ; — BJOG ; 5— More than one previous caesarean delivery: a 5-year experience with patients. Caesarean section and risk of unexplained stillbirth in subsequent pregnancy.
Vaginal birth after cesarean delivery.
Share Link
Maternal and perinatal complications with uterine rupture inpatients who attempted vaginal birth after caesarean delivery: a review of the literature. Maternal and perinatal outcomes associated with a trial of labor after prior caesarean delivery.
Risk of uterine rupture during labor among women with a prior caesarean delivery. Methods of term labour induction for women with a previous caesarean section.
Cochrane Database Syst Rev. Comparison of the safety and efficacy of intravaginal misoprostol prostaglandin E1 with those of dinoprostone prostaglandin E2 for cervical ripening and induction of labor in a community hospital.
WHO recommendations for induction of labour. WHO,
